世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1099
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、多発性骨髄腫用CART細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（多発性骨髄腫、難治性/再発性多発性骨髄腫）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・多発性骨髄腫用CART細胞療法の市場動向
・企業の競争状況、市場シェア
・多発性骨髄腫用CART細胞療法の種類別市場規模（単剤療法、併用療法）
・多発性骨髄腫用CART細胞療法の用途別市場規模（多発性骨髄腫、難治性/再発性多発性骨髄腫）
・多発性骨髄腫用CART細胞療法の北米市場規模2016-2027（アメリカ、カナダ）
・多発性骨髄腫用CART細胞療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・多発性骨髄腫用CART細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・多発性骨髄腫用CART細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル）
・多発性骨髄腫用CART細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Juno Therapeutics、Kite Pharma、Novartis、Collectis）
・結論

CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual’s own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it is yet to receive an approval of the first CAR T-cell therapy for multiple myeloma.
The increasing number of collaborations or licensing agreements between companies and research institute, will induce the involvement of more investors in this area. Car T-cell therapy for multiple myeloma has identified that most of the pipeline molecules in multiple myeloma are currently in the pre-clinical development stage. KMA.CAR-T the drug is under development by the company HaemaLogiX. This monotherapy drug is currently in the pre-clinical stage and the company has already signed an agreement with Westmead Institute for Medical Research.

Market Analysis and Insights: Global CAR T-Cell Therapy for Multiple Myeloma Market
The global CAR T-Cell Therapy for Multiple Myeloma market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CAR T-Cell Therapy for Multiple Myeloma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CAR T-Cell Therapy for Multiple Myeloma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CAR T-Cell Therapy for Multiple Myeloma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CAR T-Cell Therapy for Multiple Myeloma market.

Global CAR T-Cell Therapy for Multiple Myeloma Scope and Market Size
CAR T-Cell Therapy for Multiple Myeloma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Therapy for Multiple Myeloma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monotherapy
Combination Therapy

Segment by Application
Multiple Myeloma
Refractory or Relapsed Multiple Myeloma

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Juno Therapeutics
Kite Pharma
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Multiple Myeloma
1.3.3 Refractory or Relapsed Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Perspective (2016-2027)
2.2 CAR T-Cell Therapy for Multiple Myeloma Growth Trends by Regions
2.2.1 CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 CAR T-Cell Therapy for Multiple Myeloma Historic Market Share by Regions (2016-2021)
2.2.3 CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Regions (2022-2027)
2.3 CAR T-Cell Therapy for Multiple Myeloma Industry Dynamic
2.3.1 CAR T-Cell Therapy for Multiple Myeloma Market Trends
2.3.2 CAR T-Cell Therapy for Multiple Myeloma Market Drivers
2.3.3 CAR T-Cell Therapy for Multiple Myeloma Market Challenges
2.3.4 CAR T-Cell Therapy for Multiple Myeloma Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Revenue (2016-2021)
3.1.2 Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Players (2016-2021)
3.2 Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy for Multiple Myeloma Revenue
3.4 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy for Multiple Myeloma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy for Multiple Myeloma Revenue in 2020
3.5 CAR T-Cell Therapy for Multiple Myeloma Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy for Multiple Myeloma Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
3.8 Mergers & Acquisitions, Expansion Plans

4 CAR T-Cell Therapy for Multiple Myeloma Breakdown Data by Type
4.1 Global CAR T-Cell Therapy for Multiple Myeloma Historic Market Size by Type (2016-2021)
4.2 Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Type (2022-2027)

5 CAR T-Cell Therapy for Multiple Myeloma Breakdown Data by Application
5.1 Global CAR T-Cell Therapy for Multiple Myeloma Historic Market Size by Application (2016-2021)
5.2 Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size (2016-2027)
6.2 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
6.2.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021)
6.2.2 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027)
6.2.3 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2027)
6.3 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application
6.3.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021)
6.3.2 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027)
6.3.3 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2027)
6.4 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country
6.4.1 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021)
6.4.2 North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size (2016-2027)
7.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
7.2.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021)
7.2.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027)
7.2.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2027)
7.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application
7.3.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021)
7.3.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027)
7.3.3 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2027)
7.4 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country
7.4.1 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021)
7.4.2 Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size (2016-2027)
8.2 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
8.2.1 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2027)
8.3 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Application
8.3.1 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2027)
8.4 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Region
8.4.1 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size (2016-2027)
9.2 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
9.2.1 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021)
9.2.2 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027)
9.2.3 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2027)
9.3 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application
9.3.1 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021)
9.3.2 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027)
9.3.3 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2027)
9.4 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country
9.4.1 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021)
9.4.2 Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size (2016-2027)
10.2 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Type
10.2.1 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2027)
10.3 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Application
10.3.1 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2027)
10.4 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Country
10.4.1 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Juno Therapeutics
11.1.1 Juno Therapeutics Company Details
11.1.2 Juno Therapeutics Business Overview
11.1.3 Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Introduction
11.1.4 Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
11.1.5 Juno Therapeutics Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Introduction
11.2.4 Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
11.2.5 Kite Pharma Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis CAR T-Cell Therapy for Multiple Myeloma Introduction
11.3.4 Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Collectis
11.4.1 Collectis Company Details
11.4.2 Collectis Business Overview
11.4.3 Collectis CAR T-Cell Therapy for Multiple Myeloma Introduction
11.4.4 Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
11.4.5 Collectis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2016-2021)
Table 8. Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2022-2027)
Table 10. CAR T-Cell Therapy for Multiple Myeloma Market Trends
Table 11. CAR T-Cell Therapy for Multiple Myeloma Market Drivers
Table 12. CAR T-Cell Therapy for Multiple Myeloma Market Challenges
Table 13. CAR T-Cell Therapy for Multiple Myeloma Market Restraints
Table 14. Global CAR T-Cell Therapy for Multiple Myeloma Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Players (2016-2021)
Table 16. Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Therapy for Multiple Myeloma as of 2020)
Table 17. Ranking of Global Top CAR T-Cell Therapy for Multiple Myeloma Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy for Multiple Myeloma Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Therapy for Multiple Myeloma Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Therapy for Multiple Myeloma Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021) (US$ Million)
Table 24. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Type (2016-2021)
Table 25. Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global CAR T-Cell Therapy for Multiple Myeloma Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Application (2016-2021)
Table 29. Global CAR T-Cell Therapy for Multiple Myeloma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021) (US$ Million)
Table 32. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021) (US$ Million)
Table 34. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size by Country (2022-2027) & (US$ Million)
Table 61. Juno Therapeutics Company Details
Table 62. Juno Therapeutics Business Overview
Table 63. Juno Therapeutics CAR T-Cell Therapy for Multiple Myeloma Product
Table 64. Juno Therapeutics Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021) & (US$ Million)
Table 65. Juno Therapeutics Recent Development
Table 66. Kite Pharma Company Details
Table 67. Kite Pharma Business Overview
Table 68. Kite Pharma CAR T-Cell Therapy for Multiple Myeloma Product
Table 69. Kite Pharma Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021) & (US$ Million)
Table 70. Kite Pharma Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis CAR T-Cell Therapy for Multiple Myeloma Product
Table 74. Novartis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Collectis Company Details
Table 77. Collectis Business Overview
Table 78. Collectis CAR T-Cell Therapy for Multiple Myeloma Product
Table 79. Collectis Revenue in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021) & (US$ Million)
Table 80. Collectis Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Type: 2020 VS 2027
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Application: 2020 VS 2027
Figure 5. Multiple Myeloma Case Studies
Figure 6. Refractory or Relapsed Multiple Myeloma Case Studies
Figure 7. CAR T-Cell Therapy for Multiple Myeloma Report Years Considered
Figure 8. Global CAR T-Cell Therapy for Multiple Myeloma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global CAR T-Cell Therapy for Multiple Myeloma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions: 2020 VS 2027
Figure 11. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Regions (2022-2027)
Figure 12. Global CAR T-Cell Therapy for Multiple Myeloma Market Share by Players in 2020
Figure 13. Global Top CAR T-Cell Therapy for Multiple Myeloma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Therapy for Multiple Myeloma as of 2020
Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy for Multiple Myeloma Revenue in 2020
Figure 15. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Type (2016-2021)
Figure 16. Global CAR T-Cell Therapy for Multiple Myeloma Revenue Market Share by Type (2022-2027)
Figure 17. North America CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2016-2027)
Figure 19. North America CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2016-2027)
Figure 20. North America CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2016-2027)
Figure 21. United States CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2016-2027)
Figure 25. Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2016-2027)
Figure 26. Europe CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2016-2027)
Figure 27. Germany CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2016-2027)
Figure 35. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2016-2027)
Figure 36. Asia-Pacific CAR T-Cell Therapy for Multiple Myeloma Market Share by Region (2016-2027)
Figure 37. China CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2016-2027)
Figure 45. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2016-2027)
Figure 46. Latin America CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2016-2027)
Figure 47. Mexico CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Share by Type (2016-2027)
Figure 51. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Share by Application (2016-2027)
Figure 52. Middle East & Africa CAR T-Cell Therapy for Multiple Myeloma Market Share by Country (2016-2027)
Figure 53. Turkey CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE CAR T-Cell Therapy for Multiple Myeloma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Juno Therapeutics Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
Figure 57. Kite Pharma Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
Figure 58. Novartis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
Figure 59. Collectis Revenue Growth Rate in CAR T-Cell Therapy for Multiple Myeloma Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

Global CAR T-Cell Therapy for Multiple Myeloma Market Size, Status and Forecast 2021-2027
QYR2104Z1099 2021年4月 94Pages
QYResearch社発行の本調査資料では、多発性骨髄腫用CART細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（多発性骨髄腫、難治性/再発性多発性骨髄腫）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

Global Multiple Myeloma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3954 2021年4月 91Pages
QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロテアソーム阻害剤、免疫調節剤（IMiD）、ヒストンデアセチラーゼ（HDAC）阻害剤、免疫療法、細胞毒性化学療法）、用途別市場規模（病...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Multiple Sclerosis Market Size, Status and Forecast 2021-2027
QYR2104Z5441 2021年4月 90Pages
QYResearch社発行の本調査資料では、多発性硬化症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内、脳室内）、用途別市場規模（再発寛解型多発性硬化症（RRMS）、一次進行型多発性硬化症（PPMS）、二次性進行型多発性硬化症...

世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年）

世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年）

Global Multiple Myeloma Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z3953 2021年4月 96Pages
QYResearch社発行の本調査資料では、多発性骨髄腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法・その他薬剤、放射線、幹細胞移植、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Stem Cell Therapy for Osteoarthritis Market Size, Status and Forecast 2021-2027
QYR2104Z5442 2021年4月 95Pages
QYResearch社発行の本調査資料では、変形性関節症幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（単剤療法、併用療法）、用途別市場規模（変形性関節症（詳細不明）、変形性膝関節症、肩変形性関節症、股関節変形性関節症）、主要地域別市...

世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年）

Global Cancer Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1071 2021年4月 92Pages
QYResearch社発行の本調査資料では、がん幹細胞（CSC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）、用途別市場規模（病院、クリニック、医学研究機関、その他）、主要地域別市...

世界の養子細胞移植療法市場規模・現状・予測（2021年-2027年）

Global Adoptive Cell Transfer Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0108 2021年4月 159Pages
QYResearch社発行の本調査資料では、養子細胞移植療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（NK、LAK、DC、CIK、CTL、TIL、TCR-T、CAR-T）、用途別市場規模（急性リンパ性白血病、NHL、黒色腫、膀胱がん、肺が...

世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年）

Global Rheumatoid Arthritis Stem Cell Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5046 2021年4月 93Pages
QYResearch社発行の本調査資料では、関節リウマチ幹細胞治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種間葉系幹細胞、骨髄移植、脂肪組織幹細胞）、用途別市場規模（病院、外来手術センター、専門診療所）、主要地域別市場規模（北米、アメ...

世界のT細胞移植療法市場規模・現状・予測（2021年-2027年）

Global T Cell Transfer Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z5541 2021年4月 91Pages
QYResearch社発行の本調査資料では、T細胞移植療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（自家、同種異系）、用途別市場規模（子供、大人、高齢者）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、...

世界の多発性骨髄腫用CART細胞療法市場規模・現状・予測（2021年-2027年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年） Multiple myeloma is a cancer formed due to malignant plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system. Plasma cells helps to fight infections by making antibodies that recognize and attack germs. Multiple myeloma causes cancer cells to acc…
世界の多発性骨髄腫治療市場規模・現状・予測（2021年-2027年） Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma i…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
世界の多発性硬化症幹細胞治療市場規模・現状・予測（2021年-2027年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…